Expression of the T cell activation markers HLA-DR and CD38 on peripheral T cells.
Detect CD38 expression during anti-CD38 therapy – Caltag Medsystems
International Clinical Cytometry Society
CD38 expression in macrophages in HCC tissues was validated using flow... | Download Scientific Diagram
Cureus | CD38: From Positive to Negative Expression after Daratumumab Treatment | Article
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia | Leukemia
Double CD38−/CD138− negative multiple myeloma - ScienceDirect
International Clinical Cytometry Society
IJMS | Free Full-Text | Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
A86049, CD38-APC-A750 Conjugated Antibody, LS198-4-3, 0.5 mL, ASR
Anti-Hu CD38 APC - EXBIO Antibodies
Immunophenotyping in Multiple Myeloma and Others Monoclonal Gammopathies | IntechOpen
Flow cytometry CD38-gating analysis of bone marrow (A: population of... | Download Scientific Diagram
High proportion of anergic B cells in the bone marrow defined phenotypically by CD21(−/low)/CD38- expression predicts poor survival in diffuse large B cell lymphoma | BMC Cancer | Full Text
Representative flow cytometry profiles of CD38 expression in patients... | Download Scientific Diagram
Pathology Outlines - CD38
of Flow Cytometry in Plasma Cell Neoplasms | Basicmedical Key
Excellent CD38 Staining On Human PBMCs | Biocompare Antibody Review
Flow cytometry gating strategy for measuring HLA-DR and CD38 expression... | Download Scientific Diagram
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma | Journal of Hematology & Oncology | Full Text
FITC Mouse Anti-Human CD38
Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission
The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections - ScienceDirect
